A $100 million matching grant from the Weill Family Foundation is supporting the launch of the Weill Cancer Hub West—a collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center and the Stanford Cancer Institute—set up to accelerate discoveries and speed the development of innovative new treatments for patients.
In a move that will have direct impact on approval of cancer drugs, George Francis Tidmarsh, an oncologist and a longtime pharmaceutical executive, was named director of the FDA Center for Drug Evaluation and Research.
